(0.36%) 5 173.25 points
(0.32%) 38 957 points
(0.28%) 18 052 points
(1.10%) $78.97
(1.07%) $2.17
(0.84%) $2 328.00
(2.67%) $27.40
(0.98%) $974.75
(-0.03%) $0.929
(-0.34%) $10.84
(-0.22%) $0.795
(-0.06%) $91.40
2 days till quarter result
(bmo 2024-05-08)
Expected move: +/- 0.00%
Live Chart Being Loaded With Signals
Nipro Corporation, together with its subsidiaries, engages in the medical devices, pharmaceuticals, and pharma packaging businesses. The company's Medical Device business develops, manufactures, and sells various disposable medical products comprising renal, intervention and anesthesiology, injection and infusion, dialysis, cardiopulmonary, diabetic, and cell cultures products; and sells artificial organ-related products, and generic and kit products...
Stats | |
---|---|
आज की मात्रा | 356 700 |
औसत मात्रा | 614 091 |
बाजार मूल्य | 206.07B |
EPS | ¥0 ( 2024-02-07 ) |
अगली कमाई की तारीख | ( ¥14.64 ) 2024-05-08 |
Last Dividend | ¥8.50 ( 2023-03-30 ) |
Next Dividend | ¥0 ( N/A ) |
P/E | 22.73 |
ATR14 | ¥0.575 (0.05%) |
मात्रा सहसंबंध
Nipro Corporation सहसंबंध
10 सबसे अधिक सकारात्मक सहसंबंध |
---|
10 सबसे अधिक नकारात्मक सहसंबंध |
---|
क्या आप जानते हैं?
कोरलेशन एक सांख्यिकीय माप है जो दो चरों के बीच संबंध का वर्णन करता है। यह -1 से 1 तक का होता है, जहाँ -1 एक पूर्ण नकारात्मक कोरलेशन को दर्शाता है (जैसे ही एक चर बढ़ता है, दूसरा कम होता है), 1 एक पूर्ण सकारात्मक कोरलेशन को दर्शाता है (जैसे ही एक चर बढ़ता है, दूसरा भी बढ़ता है) और 0 कोई कोरलेशन नहीं होता है (चरों के बीच कोई संबंध नहीं है)।
कोरलेशन किसी भी दो चरों के बीच संबंध का विश्लेषण करने के लिए इस्तेमाल किया जा सकता है, न कि केवल स्टॉक में। यह वित्तीय, अर्थशास्त्र, मनोविज्ञान और अन्य क्षेत्रों में आमतौर पर उपयोग किया जाता है।
Nipro Corporation सहसंबंध - मुद्रा/वस्त्र
Nipro Corporation वित्तीय
Annual | 2022 |
राजस्व: | ¥545.20B |
सकल लाभ: | ¥163.45B (29.98 %) |
EPS: | ¥28.04 |
FY | 2022 |
राजस्व: | ¥545.20B |
सकल लाभ: | ¥163.45B (29.98 %) |
EPS: | ¥28.04 |
FY | 2022 |
राजस्व: | ¥494.79B |
सकल लाभ: | ¥149.27B (30.17 %) |
EPS: | ¥82.50 |
FY | 2021 |
राजस्व: | ¥455.56B |
सकल लाभ: | ¥138.84B (30.48 %) |
EPS: | ¥87.12 |
Financial Reports:
No articles found.
Nipro Corporation Dividends
(Q3/22) | (Q4/22) | (Q1/23) | (Q2/23) | (Q3/23) | (Q4/23) | (Q1/24) | (Q2/24) | (Q3/24) | (Q4/24) |
¥13.50 (N/A) |
¥0 (N/A) |
¥8.50 (N/A) |
¥0 (N/A) |
¥0 (N/A) |
¥0 (N/A) |
¥0 (N/A) |
¥0 (N/A) |
¥0 (N/A) |
¥0 (N/A) |
Very Unsafe
High risk of being cut
Unsafe
Heightened risk of being cut
Borderline
Moderate risk of being cut
Safe
Unlikely to be cut
Very Safe
Very unlikely to be cut
First Dividend | ¥8.75 | 2001-03-27 |
Last Dividend | ¥8.50 | 2023-03-30 |
Next Dividend | ¥0 | N/A |
Payout Date | 0000-00-00 | |
Next Payout Date | N/A | |
# dividends | 45 | -- |
Total Paid Out | ¥561.75 | -- |
Avg. Dividend % Per Year | 0.00% | -- |
Score | 3.13 | -- |
Div. Sustainability Score | 7.70 | |
Div.Growth Potential Score | 3.48 | |
Div. Directional Score | 5.59 | -- |
Year | Amount | Yield |
---|
The company's strong Dividend Sustainability Score (DSS) indicates its robust capacity to uphold current dividend levels. Unfortunately, its low Dividend Growth Potential Score (DGPS) suggests limited prospects for dividend growth. On the whole, the dividend outlook remains neutral, meriting close observation of both the company's financial health and growth prospects.
Symbol | Title | Last dividend | Frequency | Years Dividend | Yearly Dividend | Score |
---|---|---|---|---|---|---|
9514.T | Ex Dividend Junior | 2024-06-27 | Annually | 0 | 0.00% | |
8129.T | Ex Dividend Knight | 2023-09-28 | Semi-Annually | 0 | 0.00% | |
7467.T | Ex Dividend Knight | 2023-09-28 | Semi-Annually | 0 | 0.00% | |
6699.T | Ex Dividend Junior | 2023-09-28 | Semi-Annually | 0 | 0.00% | |
6030.T | Ex Dividend Knight | 2023-06-29 | Annually | 0 | 0.00% | |
4719.T | Ex Dividend Knight | 2023-09-28 | Semi-Annually | 0 | 0.00% | |
3962.T | Ex Dividend Junior | 2024-03-28 | Annually | 0 | 0.00% | |
3172.T | Ex Dividend Knight | 2024-01-30 | Semi-Annually | 0 | 0.00% | |
2154.T | Ex Dividend Knight | 2023-12-28 | Semi-Annually | 0 | 0.00% | |
9039.T | Ex Dividend Knight | 2023-09-28 | Semi-Annually | 0 | 0.00% |
Ratio | Actual Value | Weight | Normalized Value | Score | Range |
---|---|---|---|---|---|
netProfitMarginTTM | 0.0177 | 1.500 | 9.65 | 10.00 | [0 - 0.5] |
returnOnAssetsTTM | 0.00921 | 1.200 | 9.69 | 10.00 | [0 - 0.3] |
returnOnEquityTTM | 0.0455 | 1.500 | -0.605 | -0.908 | [0.1 - 1] |
payoutRatioTTM | 0 | -1.000 | 0 | 0 | [0 - 1] |
currentRatioTTM | 1.495 | 0.800 | 7.52 | 6.02 | [1 - 3] |
quickRatioTTM | 0.717 | 0.800 | -0.486 | -0.389 | [0.8 - 2.5] |
cashRatioTTM | 0.222 | 1.500 | 9.88 | 10.00 | [0.2 - 2] |
debtRatioTTM | 0.539 | -1.500 | 1.023 | -1.534 | [0 - 0.6] |
interestCoverageTTM | 4.49 | 1.000 | 9.45 | 9.45 | [3 - 30] |
operatingCashFlowPerShareTTM | 686.29 | 2.00 | 10.00 | 10.00 | [0 - 30] |
freeCashFlowPerShareTTM | 686.29 | 2.00 | 10.00 | 10.00 | [0 - 20] |
debtEquityRatioTTM | 2.46 | -1.500 | 0.157 | -0.236 | [0 - 2.5] |
grossProfitMarginTTM | 0.300 | 1.000 | 8.33 | 8.33 | [0.2 - 0.8] |
operatingProfitMarginTTM | 0.0466 | 1.000 | -1.069 | -1.069 | [0.1 - 0.6] |
cashFlowToDebtRatioTTM | 0.187 | 1.000 | -0.0728 | -0.0728 | [0.2 - 2] |
assetTurnoverTTM | 0.520 | 0.800 | 9.87 | 7.89 | [0.5 - 2] |
Total Score | 7.70 |
Ratio | Actual Value | Weight | Normalized Value | Score | Range |
---|---|---|---|---|---|
peRatioTTM | 20.12 | 1.000 | 8.07 | 0 | [1 - 100] |
returnOnEquityTTM | 0.0455 | 2.50 | -0.389 | -0.908 | [0.1 - 1.5] |
freeCashFlowPerShareTTM | 686.29 | 2.00 | 10.00 | 10.00 | [0 - 30] |
dividendYielPercentageTTM | 1.979 | 1.500 | 10.00 | 0 | [0 - 0.4] |
operatingCashFlowPerShareTTM | 686.29 | 2.00 | 10.00 | 10.00 | [0 - 30] |
payoutRatioTTM | 0 | 1.500 | 0 | 0 | [0 - 1] |
pegRatioTTM | -3.79 | 1.500 | -10.00 | 0 | [0.5 - 2] |
operatingCashFlowSalesRatioTTM | 0.194 | 1.000 | 7.66 | 0 | [0.1 - 0.5] |
Total Score | 3.48 |
Nipro Corporation
Nipro Corporation, together with its subsidiaries, engages in the medical devices, pharmaceuticals, and pharma packaging businesses. The company's Medical Device business develops, manufactures, and sells various disposable medical products comprising renal, intervention and anesthesiology, injection and infusion, dialysis, cardiopulmonary, diabetic, and cell cultures products; and sells artificial organ-related products, and generic and kit products. Its Pharmaceutical business provides pharmaceutical combination products, including dual chamber bags, pre-filled syringes, and half-type kits; and contract manufacturing services for orally administered drugs, injectables, and external preparations. The company's Pharma Packaging business offers glass vials, ampoules, syringes, and cartridges; glass tubes; glass forming machinery; glass bulbs for vacuum flasks; and other parts of pharmaceutical packaging, such as rubber plugs. Its Other business provides thermostable enzymes for clinical chemistry. The company also offers business management services. Nipro Corporation serves customers in Japan, the Americas, Europe, and rest of Asia. The company was founded in 1947 and is headquartered in Osaka, Japan.
के बारे में लाइव सिग्नल्स
इस पृष्ठ पर प्रस्तुत लाइव सिग्नल्स NA को कब खरीदना या बेचना है, इसका निर्धारण करने में मदद करते हैं। सिग्नल्स में 1-मिनट की देरी हो सकती है; सभी बाजार सिग्नल्स की तरह, त्रुटि या गलतियों की संभावना होती है।
लाइव ट्रेडिंग सिग्नल्स स्थायी नहीं हैं, और getagraph.com इन सिग्नल्स पर किए गए किसी भी कार्रवाई के लिए जिम्मेदारी नहीं रखते हैं, जैसा कि उपयोग की शर्तें में वर्णित है। सिग्नल्स एक व्यापक श्रृंखला के तकनीकी विश्लेषण संकेतकों पर आधारित हैं